AHA Coding Clinic (Recent Guidance) The AHA Coding Clinic has issued several relevant pieces of guidance on amputation coding over recent years
These effects occurred in 4070% of treated patients in clinical trials
Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]
Helpful context before the funnel FormBlends Editorial Context Reviewed May 14, 2026 Compare Mochi Health vs Ro for GLP-1 weight loss medications
Considering the promising results of the SURPASS and SURMOUNT trials, what additional factors or challenges must researchers address before adopting tirzepatide for conditions beyond Type 2 diabetes, such as non-alcoholic fatty liver disease (NAFLD)